BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
58 hedge funds and large institutions have $146M invested in Biotech Acquisition Company Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
+7
Holders Change %
+13.73%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
13
Reduced
4
Closed
6
Calls
$98K
Puts
–
Net Calls
+$98K
Net Calls Change
+$12K
Top Buyers
1 |
SRCM
Sage Rock Capital Management
New York
|
$5.59M |
2 |
D.E. Shaw & Co
New York
|
$5.16M |
3 |
SCM
Saba Capital Management
New York
|
$8.81M |
4 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
$2.19M |
5 |
![]()
Marshall Wace
London,
United Kingdom
|
$3.08M |